{
  "image_filename": "table_p5_det_4_007.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/table_p5_det_4_007.png",
  "image_type": "Table",
  "page_number": 5,
  "block_id": "det_4_007",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table presenting demographic and clinical measures (race, sex, season, influenza case rate, high-risk condition) for two age groups (18\u201364 years and \u226565 years) by vaccine received (RIV4, SD-IIV4, and combinations including HD-IIV4 and Adjuvanted IIV). It shows counts, percentages, and P-values comparing vaccine groups. does not support the claim because the table only provides demographic breakdowns and influenza case percentages by vaccine type without any information on vaccine production methods, mutations during production, or their effect on effectiveness.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table presenting demographic and clinical measures (race, sex, season, influenza case rate, high-risk condition) for two age groups (18\u201364 years and \u226565 years) by vaccine received (RIV4, SD-IIV4, and combinations including HD-IIV4 and Adjuvanted IIV). It shows counts, percentages, and P-values comparing vaccine groups.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only provides demographic breakdowns and influenza case percentages by vaccine type without any information on vaccine production methods, mutations during production, or their effect on effectiveness.",
    "confidence_notes": null
  }
}